VALUE solution is supported by EIT Health and joins prominent clinical (6 hospitals), industry (3 business partners), and academic and technical partners (5 universities and 1 assessment agency) to support clinical pathways optimization as a required step to change to a Value-Based Healthcare model.
Karolinska Institutet is one of the world’s foremost medical universities. Our vision is to advance knowledge about life and strive towards better health for all. As a university, KI is Sweden’s single largest centre of medical academic research and offers the country’s widest range of medical courses and programmes. Since 1901 the Nobel Assembly at Karolinska Institutet has selected the Nobel laureates in Physiology or Medicine. Karolinska Institutet was founded by King Karl XIII in 1810 as an “academy for the training of skilled army surgeons”. Today, Karolinska Institutet is a modern medical university and one of the foremost in the world. With our close relationship to the clinical milieu, a well established infrastructure and a stable financial situation, Karolinska Institutet has excellent prerequisites for sustaining high quality research and educationKarolinska Institutet offers the widest range of medical education under one roof in Sweden. Several of the programmes include clinical training or other training within the healthcare system. Research at Karolinska Institutet spans the entire medical field, from basic experimental research to patient-oriented and nursing research.
Research at Karolinska Institutet is conducted in 22 departments, most of which are situated or adjacent to Stockholm’s teaching hospitals. This creates ample opportunities for translational research in which new experimental results are rapidly implemented for patient benefit, and where clinical observations provide a basis for new research ideas.
Contact person:
Centro Hospitalar e Universitário de Coimbra (C.H.U.C) is a public healthcare complex located in Coimbra. It is composed by 6 medical institutions: Hospital da Universidade, Hospital Geral, Hospital Pediátrico, Maternidade Bissaya Barreto, Maternidade Dr. Daniel de Matos and Hospital Sobral Cid. It’s the biggest healthcare centre in Portugal, with almost 2000 beds and 8500 patients consulted per day.
The Cardiology Department is located at Hospital da Universidade and Hospital Geral. It is a Reference Centre for Structural & Interventional Cardiology and Congenital Heart Disease. It is composed by several units: Coronary Intensive Care Unit (UCIC), Advanced Heart Failure Care Unit (UTICA), Cardiovascular Intervention Unit (UNIC), Electrophysiology/Pacing Unit and Clinical Research in Cardiology Unit. It has a broad spectrum of diagnostic tests as cardiac computerized tomography scan, myocardial perfusion scintigraphy and cardiac magnetic resonance imaging. It also has the highest rates of consultation and hospitalization per year in Portugal, besides an outpatient clinic and a telemedicine program to help primary care centres.
Our mission is to prevent and provide the best possible care to all patients with cardiovascular disease, make innovative science and promote excellence in education.
Erasmus MC is the largest university medical centre in the Netherlands. In addition to having the largest number of university hospital disciplines in the country, it includes excellent health science and basic research departments. The Department of Public Health is one of the top medical research institutes in Europe. Its research is conducted in close collaboration with local, national and international public health or health care organizations. The department was the coordination centre of many international studies on health and health care funded by different funding bodies such as the European Commission. Furthermore, research is embedded in the Netherlands Institute of Health Sciences research school, which is acknowledged and rated as excellent by the Royal Netherlands Academy of Arts and Sciences. Central themes in the long-term strategy of Erasmus MC is to continuously add value by working with the patient as a partner and with healthy workers. Since 2014 Erasmus MC has developed an extensive program on value-based healthcare.
Institut Català de la Salut with a staff of over 42,000 professionals, the Catalan Health Institute (ICS) is the largest public health services company of Catalonia, that provides health care to nearly six million people across the country.
As a reference entity of the public health system, the aim of ICS is to improve people’s health and quality of life, through the provision of innovative and excellent health services, regarding both the promotion of health and the treatment of diseases, from the most prevalent to the most complex ones.
Vall d’Hebron Barcelona Hospital Campus as a part of the Institut Català de la Salut is a world-class healthcare park where assistance, research, teaching and innovation go hand in hand. We are the sum of five institutions: Vall d’Hebron University Hospital, Vall d’Hebron Research Institute, Vall d’Hebron Institute of Oncology, the Multiple Sclerosis Center of Catalonia and Universitat Autònoma de Barcelona. We work together with the same pioneering spirit and a common goal: to improve the health and well-being of people. In a complex of 22 buildings, 9,000 professionals attend 1,200,000 patients every year. Through VHIR and VHIO institutes, Vall d’Hebron has 83 research groups that carry out more than 900 clinical trials and produce more than 1,100 scientific publications a year.
Institute of Biomedical Research of Salamanca was created in March 2011 as a result of a collaboration agreement between the Health Department of the Castile and Leon regional government, the University of Salamanca (USAL), and the Superior Scientific Research Council (CSIC), in order to raise the research quality, and as a result, the teaching and healthcare levels of the Salamanca University Hospital (HUS), the core of the Institute. The mission of the IBSAL is to advance clinical and translational research, promoting synergy between clinical and basic research groups, as well as optimizing resources through common services and more efficient management structures. The vision is to become the benchmark Healthcare Research Institute for the Castile and Leon and west Portugal regions, and to be an international benchmark in Cancer, Neuroscience and Cardiovascular and, as time goes by, in other potential research areas.
The 2017-2021 IBSAL Strategic Plan defines 3 main strategic objectives: 1. Communication, networking and alliances. 2. Organization and resources. 3. Innovation and transfer.
The research activities of the centre are divided into six different areas, including the Area of Neurosciences, which group 43 top-level research teams. The number of researchers working in IBSAL is currently 545 (226 PhDs), and they all have complimentary basic/translational and clinical profiles. In addition, there is a sizeable team of qualified graduates in different fields and trainees dedicated to research tasks that support the lines of study of the IBSAL scientists.
IBSAL provides all the needed state-of-the-art equipment and facilities necessary for the proposal. Relevant research facilities for the project are Animal Care Service, Animal Behaviour Research Unit, Proteomic and Genomic Units, Biobank, Citometry and Cell Sorting, Cell Culture Unit, Microscopy (confocal and electronic microscopy), Bioinformatics and Biostatistics Unit.
Servicio Madrileño de Salud is the public body in charge of the public health benefits system in the Community of Madrid. SERMAS is the administrative and management structure that integrates almost all public hospital, primary care centres, emergency services and every public health service of the Madrid Regional Public Health System. SERMAS has participated in 41 H2020 projects so far, plus several EIT_Health Campus and Innovation projects. The Foundation for the Biohealth Innovation and Research on Primary Care (FIIBAP) of Madrid is a non-profit organization whose goal is to promote the internationalization of primary health related research in Madrid Region”.
Fundación Investigación Biomédica of Hospital Clínico San Carlos (FIB HCSC) handles the biomedical research resources of the Instituto Investigación Sanitaria Hospital Clínico San Carlos (IdISSC). IdISSC is a biomedical research union between Hospital Clínico San Carlos (HCSC), Complutense University of Madrid (UCM) and Fundación Investigación Biomédica of Hospital Clínico San Carlos (FIB HCSC). FIB HCSC is situated within the premises of the HCSC.
This Institute was conceived as a functional structure for multidisciplinary and translational biomedical research of excellence, aimed at basic, clinical, epidemiological and health service research situated within the HCSC complex. The mission of the IdISSC is to promote and consolidate biomedical research activities of the groups which make up the Institute, building an organization of excellence where scientific knowledge is generated and applied in clinical practice, thus improving citizen´s health. The goals of this Institution are to foster collaboration between different research groups to focus on translational research, improve the transfer of scientific knowledge and dissemination, and attract companies in order to enhance the development and innovation of scientific health activities.
Contact persons:
Servicio Madrileño de Salud
Carlos Estévez Muñoz
Ricardo Rodríguez Barrientos
Hospital Clínico San Carlos
The Stockholm region is responsible for all publicly funded healthcare and public transport in Stockholm County. The Region Stockholm Assembly is also responsible for other overall issues within the county, such as regional planning and cultural grants.
Greater Stockholm is Sweden’s leading region and financial centre. Today, the region attracts people from other countries, visitors and investors. It ranks highly in terms of quality of life – public health is good, and the level of education is high.
Karolinska University Hospital is one of the top medical centres in Europe. We believe that patient care, research and education must all play equally strong roles in our effort to extend and enhance people’s lives.
We have 15,800 employees, 1,600 inpatient beds and a turnover of approximately 1.7 BEUR.
Medtronic is a worldwide leading Healthcare Technology Innovation Company – alleviating pain, restoring health and extending life for millions of people around the world. Every year, Medtronic provides medical professionals with products and therapies to help improve the lives of 2 patients each second. Medtronic has a wide range of CE marking, and FDA approved products and therapies, in the cardiovascular field, for Heart Failure and Coronary Heart Disease and has also a wide expertise in mHealth development, chronic disease management, remote monitoring, business development, health economy and health technology systems.
Founded in 1949, Medtronic now serves physicians, clinicians and patients in more than 120 countries. The company is headquartered in Minneapolis, Minnesota, has research, manufacturing, education and sales facilities around the world. Medtronic employs more than 80,000 people worldwide. Medtronic Ibérica S.A. operates in Spain distributing products, performing clinical research and running educational programs to medical professionals involved in the areas and therapies of our expertise. The workforce in Spain is now more than 700 employees.
Since 2008 the company has adopted a global strategy for R&D, extending its research centers to new locations in Europe like Spain, from where there is a special focus on the development of services and platforms for the diagnosis and management of chronic diseases. Since 2012 Medtronic has incorporated a new business unit called “Integrated Health Solutions” from which it is developing solutions that encompass products and services, bringing operational excellence and efficiency into different hospital units. Therefore, Medtronic has gradually evolved from a medical device company to a Health solutions and services company with focus on the development of new and innovative technics, therapies and technologies to solve clinical problems and make these solutions accessible to Health Care professionals and the population.
Atos is a global leader in digital transformation with approximately 100,000 employees in 73 countries and annual revenue of around € 13 billion. The European number one in Big Data, Cybersecurity, High Performance Computing and Digital Workplace, The Group provides Cloud services, Infrastructure & Data Management, Business & Platform solutions, as well as transactional services through Worldline, the European leader in the payment industry. With its cutting-edge technologies, digital expertise and industry knowledge, Atos supports the digital transformation of its clients across various business sectors: Defense, Financial Services, Health, Manufacturing, Media, Energy & Utilities, Public sector, Retail, Telecommunications and Transportation. Feel free to navigate through our website. The Group is the Worldwide Information Technology Partner for the Olympic & Paralympic Games and operates under the brands Atos, Atos Consulting, Atos Worldgrid, Bull, Canopy, Unify and Worldline. Atos SE (Societas Europaea) is listed on the CAC40 Paris stock index.
Atos Research & Innovation (ARI) is the R&D hub for emerging technologies and a key reference for the whole Atos group. With almost 30 years of experience in running Research, Development and Innovation projects, we have become a well-known player in the EU context. Our multidisciplinary and multicultural team has the skills to cover all the activities needed to run projects successfully, from scientific leadership to partnership coordination, from development of emerging technologies to the exploitation of project outcomes, with a strong focus on dissemination, innovation adoption and commercialization.
ARI is represented in the project by the Health sector, which is composed of a group of engineers, biologists, bio-informaticians, mathematicians and doctors specialized in applied research and development of bio and health related projects. Here, you will find all information about Ari in the health sector. The Health sector has a wide experience in health standards (HL7 FHIR, CEN/ISO EN13606, openEHR archetypes) and well-known vocabularies such as SNOMED CT implementing standard-based Clinical Data Repository (CDR) and Terminology Service solutions to formalize the medical information. Click here to know more about our assets.
MYSPHERA’s vision is to empower Clinicians, Patients, and Healthcare Management with smart sensor-driven on-demand actionable information to improve patient care outcomes while increasing efficient management of resources in hospitals, senior living, and patient homes. Internet of Things seeks to centralize monitoring and control of all the operations taking place in healthcare organizations. Cost efficiency, reliability, and safety are the desired goals achieved with IoT applications in healthcare sector, as it is our platform, which is based on our RTLS (Real Time Location System), a wide set of IoT devices, and third party BLE devices (Bluetooth Low Energy) compliance. Our platform exchanges data with our applications through the cloud.
– Healthcare providers win process visibility to improve efficiency, efficacy and optimization of resources in real time and thanks to data analysis.
– Patients win safety in the clinical process, and relatives get more satisfaction because they are informed in real time about the patient status in the clinical process and location.
– Visualizing healthcare processes in real time saves costs, improves efficiency and increases patient’s safety.
Universidad Politécnica de Madrid (UPM) – Technical University of Madrid is the largest Spanish technological university. With two recognitions as Campus of International Excellence, it is outstanding in its research activity together with its training of highly-qualified professionals, competitive at an international level. More than 2,400 researchers carry out their activity at the UPM, grouped in 204 Research Groups, 19 Research Centers or Institutes and 55 Laboratories, all of them committed to transform the knowledge generated into innovation advances applied to the production sector, contributing to solve the challenges of the European citizens.
The intense collaboration with governmental bodies and industry guarantees that research at the UPM offers real solutions to real-world problems. The dynamism of R&D&I activity at the UPM, together with the transfer of knowledge to society, is among its lines of strategy. UPM signs annually around 600 contracts with private businesses, due to its traditional and close relationship with the industrial and business sector, which supports and back its research and technology development in all Engineering fields, Aeronautics, Agronomy, Architecture, Energy, Forestry, Industrial, Mining, Naval and Informatics and Telecommunication.
Moreover, every year, UPM applies for around 40 patents and receives a similar number of concessions demonstrating a high commitment to innovation. One of the main UPM technology transfer driver is the business creation, such as ActúaUPM internal program that has generated 140 businesses in the last 10 years, 80% of which still exists. All this shows that UPM is an institution committed to the transfer of knowledge generated through its research structures to society, and its transformation into advances and technological developments applied to the productive sector.
Universitat Politécnica de València is considered one of the top leading universities in Spain, being the single Science and Technology University in Spain to feature in all worlds’ university rankings. UPV has participated in 129 FP7 actions and led 20 of them. In H2020, UPV is a dynamic, innovative, public institution, dedicated to research and teaching that keeps strong ties with the social environment in which its activities are performed and, simultaneously, has an important presence abroad. Today, over 39,000 members integrate our academic community: 35,000 of these are students, 2,387 are teachers and 1,593 belong to administration. UPV includes 15 faculty centres: ten schools, three faculties, two higher polytechnic schools (Alcoy and Gandia), and five associated institutions.
UPV-ITACA (Research Institute), specifically SABIEN group (Technologies for Health and Well-Being), is the major research group in wellbeing and e-Health of the UPV, and one of the most relevant ones at the national level, with a research trajectory of more than 20 years. The group is the coordinator of the Healthy Living micro cluster of the VLC-CAMPUS, bringing together a multidisciplinary team of almost 20 technology and health researchers including medical doctors and engineers. This collaboration enables the work developed by the group to combine the joint expertise of the two worlds bringing together the technological background, the health knowledge, the connection with the decision takers and policy makers, the deep comprehension of the social, healthcare and public health services and initiatives in the country and a wide experience in management and dissemination of complex and multidisciplinary research projects.
SABIEN has a wide experience in the application of Process Mining technologies. Apart from VALUE project, the group is currently working in H2020 and national funded projects applying Process Mining techniques like CROWDHEALTH, LIFECHAMPS and INADVANCE among others..
The University of Coimbra (UC), Portugal, was founded in the year 1290 and comprises eight Faculties, more than 2000 teachers and 25000 students. UC comprises 150 research centres and units that conduct research and provide specialised services.
The participation in the proposed project is carried out through the Health Informatics Lab of the Adaptive Computation Group (ACG) of the Centre of Informatics and Systems of the University of Coimbra (CISUC). CISUC is a large Portuguese research centre in the fields of Informatics and Communications, which was created in 1991 and it is ranked as excellent by the Portuguese Foundation of Science and Technology. The Centre is organized in 6 research groups, covering a substantial segment of the classic research topics on computer engineering & informatics, with increasing activity on multidisciplinary research subjects, having a strong focus on computer science for health.
The Health Informatics Lab has been active since 2003 and includes 8 professors, 3 post-docs and 18 Ph.D. students. The main core expertise of the Health Informatics Lab concerns R&D for biosignal analysis, machine learning, pattern recognition, intelligent data analysis, multi-parametric modelling and complex systems integrating data driven as well as knowledge driven approaches. The group has a vast experience in fundamental and applied research on real-time biosignal analysis (ECG, PPG, EEG, BP, Heart Sounds, accelerometers, etc.) and their application in deployment of personal health solutions in real-life settings capable of handling multiple noise sources, data incompletion as well as exploring data redundancies from multiple sources/modalities. Furthermore, it has a large experience and competencies in machine learning based modelling (e.g., development of risk models, autonomous nervous system, etc.), information fusion, personalised and interpretable machine learning based algorithm development for medical diagnosis and prognosis monitoring applications and medical decision support.
At the INSTITUTO DE BIOMECÁNICA (IBV) we develop and transfer scientific knowledge and technologies to improve people’s health, well-being and quality of life, adding value to companies and the social and economic environment.
Our motto is “INNOVATION IN THE CARE OF PEOPLE”.
At IBV we study the behavior of the human body and its relationship with the products, environments and services that people use.
We combine knowledge from biomechanics, ergonomics and emotional engineering that, through different areas of knowledge, we apply to multiple sectors in order to respond to their challenges and contribute to promoting business innovation.
We work globally in Automotive, Habitat, Mobility, Clothing, Tourism and Leisure, Sport, Rehabilitation and personal autonomy, Healthcare Technology, Occupational health and well-being, Children and childcare and the Elderly People and Aging.
We believe in the contribution of exceptional value through the transfer of research results in the form of exceptional technologies and services that contribute to promoting business innovation, in the valorization of knowledge by developing independent R & D & I perfectly connected with the needs of our economic, technological and social environment, open to our clients, defined and promoted by our entire organization and in the promotion of + agile talent as a driver of change and innovation, to achieve an agile, professional, collaborative and people-centered IBV.
Contact persons:
